Additionally, in cancer patients receiving ICIs, some biomarkers such as vascular cell adhesion molecule 1 (sVCAM-1) and interleukin 8 (IL-8) were associated with the occurrence of VTE [39]. This evidence concerns the gene CXCL8 and cancer.